Home›Search›Future Oncology

Future Oncology

Taylor and Francis Ltd. · United Kingdom · Est. 2005

ISSN1744-8301

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

181

days submission → published

measured · last 19 articles · accept 159d

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.229

H-Indexi

110

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.719

Total Worksi

5,542

Total Citationsi

96,628

2yr Mean Citednessi

2.12

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Future Oncology is a MEDLINE-indexed peer-reviewed journal that offers insights into cancer treatments, personalized strategies, and their clinical implications. It covers Biochemistry, Genetics and Molecular Biology, Medicine, and Cancer Research.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2005

FrequencyForty No. A Year, 2022-

StatusActive (last: 2026)

Total Publications5,542

Publisher OrgFuture Medicine

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1744-8301

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

371

7.5k

2019

367

6.8k

2020

432

6.6k

2021

353

3.8k

2022

297

2.1k

2023

307

1.4k

2024

350

546

2025

142

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

OncologyQ1

Cancer ResearchQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesLung Cancer Research StudiesHER2/EGFR in Cancer ResearchProstate Cancer Treatment and ResearchGastric Cancer Management and OutcomesLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis

Frequently asked questions about Future Oncology

Is Future Oncology a predatory journal?

PubScope has no integrity flags on record for Future Oncology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Future Oncology?

Future Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.12.

Is Future Oncology indexed in Scopus and Web of Science?

Future Oncology is indexed in Web of Science, Scopus.